Accelerated Transfer moves Orphan Drug Product to Manufacture Faster
Accelerated Transfer moves Orphan Drug Product to Manufacture Faster
1 PagesBurnside Accelerated Transfer moves Orphan Drug Product to Manufacture Faster Challenge A medically necessary drug product was at risk of becoming unavailable in the market- place. The pharmaceutical company that purchased the rights to this orphan drug faced the stipulation that the product could not be manufactured at the original site. The company requested an accelerated transfer plan for manufacture by AAIPharma Services, noting the urg
